Stock Yards Bank & Trust Co. Sells 10,904 Shares of Zoetis Inc. $ZTS

Stock Yards Bank & Trust Co. cut its stake in shares of Zoetis Inc. (NYSE:ZTS) by 10.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 90,657 shares of the company’s stock after selling 10,904 shares during the period. Stock Yards Bank & Trust Co.’s holdings in Zoetis were worth $13,265,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in ZTS. Halbert Hargrove Global Advisors LLC boosted its stake in Zoetis by 496.6% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after purchasing an additional 144 shares during the period. REAP Financial Group LLC lifted its holdings in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after buying an additional 131 shares in the last quarter. NewSquare Capital LLC boosted its position in shares of Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after acquiring an additional 85 shares during the period. ORG Partners LLC grew its stake in shares of Zoetis by 56.8% in the second quarter. ORG Partners LLC now owns 232 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares in the last quarter. Finally, Financial Consulate Inc. bought a new position in Zoetis during the third quarter worth about $39,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Morgan Stanley set a $160.00 target price on shares of Zoetis in a research report on Thursday, December 18th. Bank of America downgraded Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price target on the stock. in a research report on Monday, December 15th. JPMorgan Chase & Co. lowered their price objective on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Stifel Nicolaus cut their target price on Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. Finally, Barclays started coverage on Zoetis in a report on Monday, December 8th. They set an “equal weight” rating and a $136.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $160.18.

Zoetis Stock Down 1.1%

Shares of ZTS opened at $123.24 on Wednesday. The firm has a 50 day simple moving average of $123.37 and a two-hundred day simple moving average of $138.85. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. Zoetis Inc. has a one year low of $115.25 and a one year high of $177.40. The company has a market cap of $54.31 billion, a P/E ratio of 20.75, a P/E/G ratio of 2.53 and a beta of 0.97.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the previous year, the firm earned $1.58 EPS. Zoetis’s revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, January 20th. This is a positive change from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s payout ratio is presently 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.